{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:19:35Z","timestamp":1782901175476,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.endonu.2015.05.006","type":"journal-article","created":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T19:27:49Z","timestamp":1435865269000},"page":"300-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prevalencia del hiperparatiroidismo secundario en pacientes con enfermedad renal cr\u00f3nica estadios 3 y 4 atendidos en medicina interna"],"prefix":"10.1016","volume":"62","author":[{"given":"Juan Carlos","family":"Bureo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Carlos","family":"Ar\u00e9valo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Ant\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaspar","family":"Adrados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Jim\u00e9nez Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s Roberto","family":"Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.endonu.2015.05.006_bib0170","doi-asserted-by":"crossref","unstructured":"Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population based studies: systematic review. BMC Public Health. 2008 Apr 11;8:117. doi: 10.1186\/1471-2458-8-117.","DOI":"10.1186\/1471-2458-8-117"},{"key":"10.1016\/j.endonu.2015.05.006_bib0175","unstructured":"National Kidney Foundation. K\/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis. 2002 (suppl 1);39:S1-S266."},{"key":"10.1016\/j.endonu.2015.05.006_bib0180","first-page":"1","article-title":"Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney, Disease","volume":"3","year":"2013","journal-title":"Kidney Int (Suppl)"},{"key":"10.1016\/j.endonu.2015.05.006_bib0185","first-page":"78","article-title":"Prevalence of chronic renal disease in Spain: Results of the EPIRCE study","volume":"30","author":"Otero","year":"2010","journal-title":"Nefrologia."},{"key":"10.1016\/j.endonu.2015.05.006_bib0190","doi-asserted-by":"crossref","first-page":"675","DOI":"10.5301\/jn.5000221","article-title":"Cross-sectional survey of the prevalence of reduced estimated glomerular filtration rate, albuminuria and cardiovascular risk in a native Spanish population","volume":"26","author":"Robles","year":"2013","journal-title":"J Nephrol."},{"issue":"Suppl.1","key":"10.1016\/j.endonu.2015.05.006_bib0195","first-page":"25","article-title":"Etiopatogenia del hiperparatiroidismo secundario: factores que afectan a la secreci\u00f3n de PTH","volume":"15","author":"Rodriguez","year":"1995","journal-title":"Nefrologia."},{"key":"10.1016\/j.endonu.2015.05.006_bib0200","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ki.1973.87","article-title":"Hyperparathyroidism and renal failure","volume":"4","author":"Arnaud","year":"1973","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"10.1016\/j.endonu.2015.05.006_bib0205","first-page":"3","article-title":"Spanish Nephrology Society Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.)","volume":"31","author":"Torregrosa","year":"2011","journal-title":"Nefrologia."},{"key":"10.1016\/j.endonu.2015.05.006_bib0210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2369-12-53","article-title":"Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: The MERENA observational cohort study","volume":"12","author":"Mart\u00ednez-Castelao","year":"2011","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.endonu.2015.05.006_bib0215","first-page":"46","article-title":"Characteristics of bone mineral metabolism in patients with stage 3-5 chronic kidney disease not on dialysis: Results of the OSERCE study","volume":"33","author":"G\u00f3rriz","year":"2013","journal-title":"Nefrologia."},{"key":"10.1016\/j.endonu.2015.05.006_bib0220","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/ndt\/gfl718","article-title":"Mineral metabolism parameters throughout chronic kidney disease stages 1-5: Achievement of K\/DOQI target ranges","volume":"22","author":"Craver","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.endonu.2015.05.006_bib0225","first-page":"620","article-title":"Adherence to K\/DOQI practice guidelines for bone metabolism and disease","volume":"13","author":"Hoy","year":"2007","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.endonu.2015.05.006_bib0230","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/ki.2008.543","article-title":"Hyperphosphatemia and hyperparathyroidism in incident chronic kidney disease patients","author":"Ramos","year":"2008","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.endonu.2015.05.006_bib0235","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Resultsof the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.endonu.2015.05.006_bib0240","first-page":"301","article-title":"Comparaci\u00f3n y concordancia de las ecuaciones de estimaci\u00f3n de filtrado glomerular de Cockcroft-Gault y MDRD en el diagn\u00f3stico de enfermedad renal cr\u00f3nica oculta","volume":"28","author":"Buitrago","year":"2008","journal-title":"Nefrologia."},{"key":"10.1016\/j.endonu.2015.05.006_bib0245","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2215\/CJN.02910707","article-title":"Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease","volume":"3","author":"Raggi","year":"2008","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.endonu.2015.05.006_bib0250","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.ehj.2003.09.010","article-title":"Parathyroid hormone and left ventricular hypertrophy","volume":"24","author":"Saleh","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.endonu.2015.05.006_bib0255","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/ki.2008.64","article-title":"Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease","volume":"73","author":"Kovesdy","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.endonu.2015.05.006_bib0260","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1185\/03007995.2012.716029","article-title":"Impact of elevated intact parathyroid hormone on mortality and renal disease progression in patients with chronic kidney disease stages 3 and 4","volume":"28","author":"Asche","year":"2012","journal-title":"Curr Med Res Opin."},{"issue":"4 Suppl 4","key":"10.1016\/j.endonu.2015.05.006_bib0265","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.ajkd.2008.11.029","article-title":"Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: An analysis from the Kidney Early Evaluation Program (KEEP)","volume":"53","author":"Bhuriya","year":"2009","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.endonu.2015.05.006_bib0270","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3109\/0886022X.2010.493982","article-title":"Hidden chronic renal insufficiency and cardiovascular events inpatients with hypertension in a primary care center","volume":"32","author":"Buitrago","year":"2010","journal-title":"Ren Fail."},{"key":"10.1016\/j.endonu.2015.05.006_bib0275","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/ki.1972.84","article-title":"On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using \u201cproportional reduction\u201d of dietary phosphorus intake","volume":"2","author":"Slatopolsky","year":"1972","journal-title":"Kidney Int."},{"key":"10.1016\/j.endonu.2015.05.006_bib0280","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/nyas.12201","article-title":"Dietary phosphorus and kidney disease","volume":"1301","author":"Uribarri","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.endonu.2015.05.006_bib0285","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/ndt\/11.supp3.22","article-title":"A deficit of calcitriol synthesis may not be the initial factor in the pathogenesis of secondary hyperparathyroidism","volume":"11","author":"Martinez","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.endonu.2015.05.006_bib0290","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ki.1994.138","article-title":"Regulation of calcitriol receptor and its messenger RNA in normal and renal failure rats","volume":"45","author":"Patel","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.endonu.2015.05.006_bib0295","first-page":"99","article-title":"Regulation of parathyroid cell gene expression in experimental uremia","volume":"1","author":"Shvil","year":"1990","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.endonu.2015.05.006_bib0300","doi-asserted-by":"crossref","first-page":"F1502","DOI":"10.1152\/ajprenal.00130.2009","article-title":"A new role for vitamin D receptor activation in chronic kidney disease","volume":"297","author":"Valdivielso","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.endonu.2015.05.006_bib0305","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1157\/13109116","article-title":"Hipovitaminosis D asociada a exposici\u00f3n solar insuficiente en la poblaci\u00f3n mayor de 64 a\u00f1os","volume":"129","author":"Vaqueiro","year":"2007","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.endonu.2015.05.006_bib0310","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.endonu.2011.03.002","article-title":"Elevada prevalencia de hipovitaminosis D en los estudiantes de medicina de Gran Canaria, Islas Canarias (Espa\u00f1a)","volume":"58","author":"Gonz\u00e1lez-Padilla","year":"2011","journal-title":"Endocrinol Nutr."},{"key":"10.1016\/j.endonu.2015.05.006_bib0315","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJMcp1009570","article-title":"Vitamin D Insufficiency","volume":"364","author":"Rosen","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endonu.2015.05.006_bib0320","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1210\/jc.2006-2250","article-title":"Low vitamin D status despite abundant sun exposure","volume":"92","author":"Binkley","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2015.05.006_bib0325","unstructured":"Zheng Z1, Shi H, Jia J, Li D, Lin S. Vitamin D supplementation and mortality risk in chronic kidney disease: a metaanalysis of 20 observational studies. BMC Nephrol. 2013 Sep 25;14:199. doi: 10.1186\/1471236914199."},{"key":"10.1016\/j.endonu.2015.05.006_bib0330","doi-asserted-by":"crossref","unstructured":"Theodoratou E, Tzoulaki l, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 2014;348:g2035 doi: 10.1136\/bmj.g2035.","DOI":"10.1136\/bmj.g2035"}],"container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092215001503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092215001503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T06:23:40Z","timestamp":1537511020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1575092215001503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1575092215001503"],"URL":"https:\/\/doi.org\/10.1016\/j.endonu.2015.05.006","relation":{},"ISSN":["1575-0922"],"issn-type":[{"value":"1575-0922","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalencia del hiperparatiroidismo secundario en pacientes con enfermedad renal cr\u00f3nica estadios 3 y 4 atendidos en medicina interna","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda y Nutrici\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endonu.2015.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 SEEN. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}